Eastgate Biotech Corp. ETBI
0.01 USD 0.00 (+0.00%)
At close·Nov 3, 2026, 4:00 PM EST
0.0001 52-week range 0.005
- YTD
- +66.67%
- 1 year
- +66.67%
Altman Z-Score
-27.26 Distress zone
Bankruptcy-risk model: below 1.81 distress, above 2.99 safe.
Piotroski F-Score
2 / 9 Weak
Nine pass/fail tests of profitability, leverage and efficiency.
P/E -4.0×
P/S 145×
P/B -1.5×
P/FCF 241×
EV/EBITDA -6.1×
EV/Sales 190×
FCF Yield 0.4%
Gross Margin -110.4%
Operating Margin -3282.4%
Net Margin -3553.7%
ROE 36.6%
ROIC 63.2%
ROA -277.7%
Revenue -26.7%
Operating Income -143.1%
EPS (diluted) -58.3%
Free Cash Flow 123.3%
Current Ratio 0.0×
Quick Ratio 0.0×
Debt / Equity -0.5×
Net Debt / EBITDA -1.5×
Interest Coverage -12.1×
Dividend Yield 0.0%
Payout Ratio 0.0%
Annual · latest fiscal year ends 2019-12-31